Paper39308
Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.
Caraceni T and 6 others. Psychopharmacology (Berl), 1979. Cited by 9 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy. Papers, record 39308. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39308
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Failure of MIF-I to affect behavioral responses in patients with Parkinson's diseases under L-dopa therapy.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Behavior | Major topic |
| Levodopa | Major topic |
| MSH Release-Inhibiting Hormone | Major topic |
| Parkinson Disease | Major topic |
| Aged | |
| Female | |
| Growth Hormone | |
| Humans | |
| Male | |
| Middle Aged | |
| Placebos | |
| Prolactin | |
| Time Factors |
Source PubMed
References23
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4,332 | A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors. | Eur J Pharmacol | 1976 | https://conductscience.org/library/papers/4332 | PubMed |
| 2 | 988,503 | Central site of action of somatostatin (SRIF): role of hippocampus. | Neuropharmacology | 1976 | https://conductscience.org/library/papers/988503 | PubMed |
| 3 | 4,633,626 | Deserpidine antagonism by a tripeptide, L-prolyl-L-leucyglycinamide. | Neuroendocrinology | 1973 | https://conductscience.org/library/papers/4633626 | PubMed |
| 4 | 4,156,639 | Pharmacological studies with a tripeptide, prolyl-leucyl glycine amide. | Arch Int Pharmacodyn Ther | 1974 | https://conductscience.org/library/papers/4156639 | PubMed |
| 5 | 5,283,931 | Regulation of formation and proposed structure of the factor inhibiting the release of melanocyte-stimulating hormone. | Proc Natl Acad Sci U S A | 1971 | https://conductscience.org/library/papers/5283931 | PubMed |
| 6 | 591,982 | Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease. | J Neurol Neurosurg Psychiatry | 1977 | https://conductscience.org/library/papers/591982 | PubMed |
| 7 | 4,569,230 | Clinical experience with hypothalamic releasing hormones. 2. Luteinizing hormone-releasing hormone and other hypophysiotropic releasing hormones. | Recent Prog Horm Res | 1972 | https://conductscience.org/library/papers/4569230 | PubMed |
| 8 | 4,569,233 | Studies on prolactin in man. | Recent Prog Horm Res | 1972 | https://conductscience.org/library/papers/4569233 | PubMed |
| 9 | 4,947,365 | DOPA potentiation by a hypothalamic factor, MSH release-inhibiting hormone (MIF). | Life Sci I | 1971 | https://conductscience.org/library/papers/4947365 | PubMed |
| 10 | 4,209,275 | Hypothalamic releasing factors and Parkinson disease. | Arch Neurol | 1974 | https://conductscience.org/library/papers/4209275 | PubMed |
| 11 | 13,412 | Effects of L-prolyl-L-leucyl-glycine amide (MIF-I) on dopaminergic neurons. | Pharmacol Biochem Behav | 1976 | https://conductscience.org/library/papers/13412 | PubMed |
| 12 | 4,640,811 | Preliminary clinical studies with L-prolyl-L-leucyl-glycine amide in Parkinson's disease. | Can Med Assoc J | 1972 | https://conductscience.org/library/papers/4640811 | PubMed |
| 13 | 13,417 | MIF, TRH, and simian social and motor behavior. | Pharmacol Biochem Behav | 1976 | https://conductscience.org/library/papers/13417 | PubMed |
| 14 | 5,064,701 | Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF). | Proc Soc Exp Biol Med | 1972 | https://conductscience.org/library/papers/5064701 | PubMed |
| 15 | 4,614,981 | Effect of melanocyte-stimulating hormone-release inhibiting factor (MIF) in Parkinson's syndrom. | Eur Neurol | 1974 | https://conductscience.org/library/papers/4614981 | PubMed |
| 16 | 4,116,150 | Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. | Lancet | 1972 | https://conductscience.org/library/papers/4116150 | PubMed |
| 17 | 4,858,836 | DOPA potentiation in ablated animals and brain levels of biogenic amines in intact animals after prolyl-leucylglycinamide. | Neuroendocrinology | 1974 | https://conductscience.org/library/papers/4858836 | PubMed |
| 18 | 14,213,659 | A SENSITIVE DOUBLE ANTIBODY IMMUNOASSAY FOR HUMAN GROWTH HORMONE IN PLASMA. | Nature | 1964 | https://conductscience.org/library/papers/14213659 | PubMed |
| 19 | 5,969,830 | Hypersensitivity induced in albino mice by melanocyte-stimulating hormone. | Nature | 1966 | https://conductscience.org/library/papers/5969830 | PubMed |
| 20 | 5,655,944 | Critical analysis of the disability in Parkinson's disease. | Mod Treat | 1968 | https://conductscience.org/library/papers/5655944 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 33,202,534 | Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics. | Pharmaceuticals (Basel) | 2020 | https://conductscience.org/library/papers/33202534 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GH1 | 2,688 | PubTator's text mining | https://conductscience.org/library/genes/2688 | NCBI Gene |
| PRL | 5,617 | PubTator's text mining | https://conductscience.org/library/genes/5617 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39308
GET https://conductscience.org/api/papers/v1/39308/references?page=2